Standout Papers

Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection 2009 2026 2014 2020 790
  1. Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection (2009)
    John G. McHutchison, Gregory T. Everson et al. New England Journal of Medicine
  2. Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection (2011)
    Kenneth E. Sherman, Steven L. Flamm et al. New England Journal of Medicine
  3. Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1 (2012)
    Anna S. Lok, David Gardiner et al. New England Journal of Medicine

Immediate Impact

7 by Nobel laureates 8 from Science/Nature 138 standout
Sub-graph 1 of 11

Citing Papers

Diagnosis and Management of Cirrhosis and Its Complications
2023 Standout
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
2020 StandoutNature
44 intermediate papers

Works of Gregory T. Everson being referenced

Population Pharmacokinetic Modeling of Plasma and Intracellular Ribavirin Concentrations in Patients with Chronic Hepatitis C Virus Infection
2015
Peginterferon Alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment[1], [2] and [3] 1 2 3☆
2004
and 34 more

Author Peers

Author Last Decade Papers Cites
Gregory T. Everson 9911 8380 3698 258 14.1k
Frederik Nevens 8915 7527 5366 427 14.9k
Bernard Portmann 9170 7957 4749 230 14.4k
Hugo R. Rosen 7762 6676 2073 195 13.5k
Daniel Dhumeaux 13549 11781 2340 272 17.5k
Peter J. Scheuer 10342 9688 2536 144 14.7k
Gary Levy 5168 3993 4379 370 13.7k
Claude Degott 8110 8182 3196 316 17.7k
Nigel Heaton 7875 4803 8920 499 15.6k
François Durand 12462 9494 7125 359 17.1k
Giorgina Mieli‐Vergani 11447 8966 7919 503 20.5k

All Works

Loading papers...

Rankless by CCL
2026